Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Price of OGK-2 shares within the framework of additional issue will be ₽0.56

3/26/24 OGKB

Moscow Exchange is thinking of launching round-the-clock trading

3/26/24 MOEX

RN-West Siberia reported for 2023 by RAS

3/26/24 CHGZ

Polymetal sees no point in maintaining its listing on Moscow Exchange

3/26/24 POLY

Gazprom reported for 2023 by RAS

3/26/24 GAZP

Polymetal plans to start underground mining at Kyzyl in 2031

3/26/24 POLY

NCSP reported for 2023 by RAS

3/26/24 NMTP

Board of Directors of MosBirch set the cut-off date for dividends

3/26/24 MOEX

Ashinsky Metallurgical Plant reported for 2023 by RAS accounting standards

3/26/24 AMEZ

Volgogradenergosbyt reported for 2023 by RAS

3/26/24 VGSB